← Back to Search

CHEC Intervention for Caregiver Support

N/A
Waitlist Available
Led By Catherine Riffin, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with sufficient cognitive capacity to consent themselves or through a legal representative
Patients aged 65-89
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the CHEC program, which helps identify and address the needs of caregivers who accompany older patients to doctor visits. It includes a checklist for caregivers' needs and a tip sheet for doctors.

Who is the study for?
This study is for older adults aged 65-89 who are cognitively intact and their family caregivers, both of whom must speak English. Caregivers must be over 21 years old. Clinicians treating patients at the Center on Aging can also participate. Those with severe hearing or visual impairments, or without mutual consent from their care dyad counterpart, cannot join.
What is being tested?
The trial is testing CHEC (Collaborative Healthcare Encounters with Caregivers), which includes a checklist to identify caregiver needs during primary care visits for seniors, plus a Tip Sheet for clinicians to address these concerns compared to usual care practices.
What are the potential side effects?
Since this intervention involves non-medical procedures like checklists and educational materials rather than drugs or medical treatments, there are no traditional side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can make my own medical decisions or have someone legally appointed to do so.
Select...
I am between 65 and 89 years old.
Select...
I speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptable length of CHEC, as measured by the proportion of caregivers who report that the checklist is an acceptable length
Accrual rate, as measured by the number of caregivers who complete the checklist
CHEC's ease of use, as measured by the proportion of caregivers who report that the checklist is easy to use
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Caregiver Checklist (CHEC)Experimental Treatment1 Intervention
CHEC is composed of two elements: 1) a checklist to identify the needs and concerns of unpaid/family caregivers who accompany older adults (aged 65+) to their primary care visits and 2) Tip Sheet for clinicians.
Group II: Usual careActive Control1 Intervention
Attendance at primary care appointments as usual.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for caregiver burnout often involve structured communication tools and support systems, similar to the CHEC intervention. These mechanisms work by systematically identifying the needs and concerns of caregivers through checklists and providing targeted advice and resources via tip sheets for clinicians. This structured approach ensures that caregivers receive personalized support, which can alleviate stress, improve coping strategies, and enhance overall well-being. Addressing caregiver burnout is crucial as it directly impacts the quality of care provided to patients and the mental and physical health of the caregivers themselves.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,084 Previous Clinical Trials
1,147,201 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,788 Previous Clinical Trials
28,184,661 Total Patients Enrolled
Catherine Riffin, PhDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
85 Total Patients Enrolled

Media Library

Collaborative Healthcare Encounters with Caregivers (CHEC) Clinical Trial Eligibility Overview. Trial Name: NCT04946942 — N/A
Caregiver Burnout Research Study Groups: Caregiver Checklist (CHEC), Usual care
Caregiver Burnout Clinical Trial 2023: Collaborative Healthcare Encounters with Caregivers (CHEC) Highlights & Side Effects. Trial Name: NCT04946942 — N/A
Collaborative Healthcare Encounters with Caregivers (CHEC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04946942 — N/A
~27 spots leftby Nov 2025